Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Eur J Nucl Med Mol Imaging ; 32(6): 668-73, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15765234

ABSTRACT

PURPOSE: Prostate cancer is the second leading cause of death from cancer among US men. Positron emission tomography (PET) with [(11)C]choline has been shown to be useful in the staging and detection of prostate cancer. The background of the increased uptake of choline in human prostate cancer is not completely understood. The aim of this study was to prospectively investigate the relationship between the [(11)C]choline uptake and the cell proliferation in human prostate cancer. METHODS: Prostate cancer tissue from 18 patients who had undergone a radical prostatectomy for histologically proven disease was studied. An [(11)C]choline PET scan was performed prior to surgery. Post-prostatectomy specimens were prepared and stained with the antibody MIB-1 for Ki-67, which depicts proliferation. Two independent observers counted the amount of stained nuclei per specimen. RESULTS: Prostate cancer showed Ki-67 staining and high uptake of [(11)C]choline. Statistical analysis showed no significant correlation between [(11)C]choline uptake and Ki-67 staining (R=0.23; P=0.34). No significant relationships were found between the uptake of [(11)C]choline (SUV) and either preoperative PSA (R=0.14; P=0.55) or Gleason sum score (R=0.28; P=0.25). CONCLUSION: In vivo uptake of [(11)C]choline does not correlate with cell proliferation in human prostate cancer as depicted by Ki-67. Our results suggest that a process other than proliferation is responsible for the uptake of [(11)C]choline in prostate cancer.


Subject(s)
Choline/pharmacokinetics , Positron-Emission Tomography/methods , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/metabolism , Aged , Carbon Radioisotopes , Cell Proliferation , Humans , Male , Middle Aged , Prostatic Neoplasms/pathology , Radiopharmaceuticals/pharmacokinetics , Statistics as Topic , Tumor Cells, Cultured
2.
Clin Cancer Res ; 10(5): 1685-90, 2004 Mar 01.
Article in English | MEDLINE | ID: mdl-15014020

ABSTRACT

PURPOSE: The aim of the study was to investigate the feasibility of (18)F-3'-fluoro-3'-deoxy-L-thymidine positron emission tomography (FLT-PET) for the detection and grading of soft tissue sarcoma (STS). EXPERIMENTAL DESIGN: Nineteen patients with 20 STSs of the extremities were scanned, using attenuation corrected whole-body FLT-PET. Standardized uptake values (SUVs) and tumor:nontumor ratios (TNTs) were compared with histopathological parameters using French and Japanese grading systems. RESULTS: Mean SUV, maximal SUV, and TNT could differentiate between low-grade (grade 1; n = 6) STS and high-grade (grade 2 and 3; n = 14) STS according to the French grading system (P = 0.001). Mean SUV, max SUV, and TNT correlated with mitotic score, MIB-1 score, the French and Japanese grading system (* = 0.550-0.747). CONCLUSIONS: FLT-PET is able to visualize STS and differentiate between low-grade and high-grade STS. The uptake of FLT correlates with the proliferation of STS.


Subject(s)
Dideoxynucleosides , Fluorine Radioisotopes , Sarcoma/diagnostic imaging , Soft Tissue Neoplasms/diagnostic imaging , Aged , Dideoxynucleosides/pharmacokinetics , Female , Fluorine Radioisotopes/pharmacokinetics , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Sarcoma/pathology , Soft Tissue Neoplasms/pathology , Tissue Distribution , Tomography, Emission-Computed/methods
SELECTION OF CITATIONS
SEARCH DETAIL